PTC Therapeutics Inc (PTCT) support and resistance · rev $806.8M
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
This page maps PTC Therapeutics Inc (PTCT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PTCT revenue for 2024-12-31 was $806.8M. Net income was -$363.3M. Revenue was down 14.0% from 2023-12-31 to 2024-12-31. PTCT currently screens at market cap $6.51B.
PTCT currently screens at market cap $6.51B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PTCT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PTCT quote page for the session range and the stock page for the full model.
Not investment advice.